Active Pregnancy, Children & Inherited Conditions Lungs & Breathing

CHOIR (childhood ocular inflammatory disease research): improving the understanding and management of sight threatening childhood onset ocular inflammation

In plain English

AI plain-English summary

Children with rare inflammatory eye diseases are being enrolled into a national registry to track their condition and treatment over time. These disorders—uveitis, scleritis, orbital inflammation, and optic neuritis—are becoming more common and more complex, yet doctors lack basic data on how they progress, what drives them, and which children will respond to treatment or suffer vision loss. The registry will standardise clinical data collected across the UK, allowing researchers to map disease distribution, natural history, and predictors of poor outcomes. The researcher will also adapt imaging tools she has already developed—which produce repeatable, sensitive measures of disease activity—and combine them with a patient-reported symptom score she created. By linking these metrics to disease type and treatment response, she aims to identify which children can safely stop immune-suppressing drugs without relapse. If successful, this work will transform management of these rare conditions from guesswork into evidence-based care, sparing children unnecessary medication and preventing avoidable blindness. It is fundamentally a population discovery science project—gathering the foundational data needed before clinical trials or new treatments can be designed.

View original technical description
Childhood ocular inflammatory disorders (ChOIDs: uveitis, scleritis, orbital inflammation and optic neuritis) are rare, complex, immune-mediated disorders with significant negative impact. ChOIDs are growing in incidence and complexity, a pattern seen in other (often associated) immune-mediated inflammatory disorders. Stubborn evidence gaps around disease distribution, determinants and endophenotypes, and around natural history and child or treatment specific predictors of poor outcome remain. Through a national childhood ocular inflammatory disease registry, and standardisation of routinely collected clinical data, supported by the national clinical and health informatic networks I have established, I will undertake the observational research needed to report disease distribution, natural history and determinants of outcome. I will also - adapt the novel imaging approaches I have developed (already shown to result in repeatable, sensitive and responsive metrics for disease state) - and use patient reported disease activity scores (with a novel tool I have developed) to interrogate correlations between these metrics and disease type (by therapeutic response or presence of multi-system immune mediated disease) and prediction of disease outcomes (e.g. successful withdrawal of systemic immunomodulatory therapy). In so doing, I will undertake the rare disease population discovery science needed to transform the understanding and management of these disorders.

View the original record at the funder ↗

Researchers

Ameenat Lola Solebo (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Developing imaging based and patient reported disease metrics to stratify childhood inflammatory eye disease: Childhood Uveitis Signs and Symptoms Study (ChUSS)
MICA: Childhood arthritis and its associated uveitis: stratification through endotypes and mechanism to deliver benefit; the CLUSTER Consortium.
Childhood arthritis and its associated uveitis: stratification through endotypes and mechanism to deliver benefit; the CLUSTER Consortium (short title: CLUSTER)
CLUSTER Childhood Arthritis and its Associated Uveitis: Stratification Through Endotypes and Mechanism to Deliver Benefit
Childhood Ocular Inflammatory Disease Research tissue Biobank (CHOIR)

Original classification

Career Development Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.